Intact Genomics Won a CDC Contract Grant

On August 29, 2016, The Centers for Disease Control and Prevention/ National Center for Emerging and Zoonotic Infectious Diseases awarded Intact Genomics a Small Business Innovation Research (SBIR) Phase I contract grant. The intent of this study is to develop the techniques and enzyme reagents for 100kb single molecule sequencing with an existing sequence platform and to enable gold-standard genomic assembly of all pathogen-vector arthropod large/complex genomes with low cost.